Edition:
United Kingdom

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

7.74USD
22 Apr 2019
Change (% chg)

$-0.03 (-0.32%)
Prev Close
$7.76
Open
$7.69
Day's High
$7.74
Day's Low
$7.65
Volume
7,611
Avg. Vol
118,762
52-wk High
$16.70
52-wk Low
$6.75

About

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $136.71
Shares Outstanding(Mil.): 18.60
Dividend: --
Yield (%): --

Financials

  ALDX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.47 -- --
ROI: -72.27 8.91 13.83
ROE: -75.02 10.06 15.25

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Aldeyra's eye drug meets main goal in late-stage study, shares surge

March 26 Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Earnings vs. Estimates